HuGE Literature Finder
Records
1
-
30
| PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina. Breast cancer research and treatment 2022 May . Gonzalez Ariana, Del Greco Franco, Vargas-Roig Laura, Brun Bianca, Tabares Gonzalo, Mampel Alejandra, Montes Cecilia, Martin Claudia, Lopez Marcela, Rossi Norma, Bruno Luisina, Ponce Carolina, Quaglio Patricia, Yanzi Alvaro, Acevedo Santiago, Lugo Lilia, Lopez Breccia Paula, Avila Silvia, Sisterna Silvina, Del Castillo María Soledad, Vazquez Martín, Nuñez Lina |
| c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial. BMC medicine 2022 Feb 20 (1): 59. Morgan Robert D, Ferreras Cristina, Peset Isabel, Avizienyte Egle, Renehan Andrew G, Edmondson Richard J, Murphy Alexander D, Nicum Shibani, Van Brussel Thomas, Clamp Andrew R, Lambrechts Diether, Zhou Cong, Jayson Gordon |
| Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness. Military medicine 2020 . Lovejoy Leann A, Turner Clesson E, Shriver Craig D, Ellsworth Rachel |
| Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact. Cancers 2020 Nov 12 (11): . Noguchi Tomoko, Iwahashi Naoyuki, Sakai Kazuko, Matsuda Kaho, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Germline mutations in cancer-predisposition genes in patients with biliary tract cancer. Oncotarget 2019 Oct 10 (57): 5949-5957. Terashima Takeshi, Umemoto Kumiko, Takahashi Hideaki, Hosoi Hiroko, Takai Erina, Kondo Shunsuke, Sakamoto Yasunari, Mitsunaga Shuichi, Ohno Izumi, Hashimoto Yusuke, Sasaki Mitsuhito, Ikeda Masafumi, Shimada Kazuaki, Kaneko Shuichi, Yachida Shinichi, Sugano Kokichi, Okusaka Takuji, Morizane Chigu |
| Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations. Breast cancer research and treatment 2019 Jul . Ademuyiwa Foluso O, Salyer Patricia, Ma Yinjiao, Fisher Sherri, Colditz Graham, Weilbaecher Katherine, Bierut Laura |
| Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing. Scientific reports 2019 Jul 9 (1): 10426. Iwahashi Naoyuki, Sakai Kazuko, Noguchi Tomoko, Yahata Tamaki, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men. European urology oncology 2019 Jul . Chandrasekar Thenappan, Gross Laura, Gomella Leonard G, Hegarty Sarah E, Leong Joon Yau, Giri Veda |
| Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast cancer research : BCR 2019 Apr 21 (1): 55. Weber-Lassalle Nana, Borde Julika, Weber-Lassalle Konstantin, Horváth Judit, Niederacher Dieter, Arnold Norbert, Kaulfuß Silke, Ernst Corinna, Paul Victoria G, Honisch Ellen, Klaschik Kristina, Volk Alexander E, Kubisch Christian, Rapp Steffen, Lichey Nadine, Altmüller Janine, Lepkes Louisa, Pohl-Rescigno Esther, Thiele Holger, Nürnberg Peter, Larsen Mirjam, Richters Lisa, Rhiem Kerstin, Wappenschmidt Barbara, Engel Christoph, Meindl Alfons, Schmutzler Rita K, Hahnen Eric, Hauke J |
| Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32 (Supplementum2): 72-78. Soukupová Jana, Lhotová Klára, Zemánková Petra, Vocka Michal, Janatová Markéta, Stolarová Lenka, Borecká Marianna, Kleiblová Petra, Machácková Eva, Foretová Lenka, Koudová Monika, Lhota Filip, Tavandzis Spiros, Zikán Michal, Stránecký Viktor, Veselá Kamila, Panczak Aleš, Kotlas Jaroslav, Kleibl Zden |
| Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer medicine 2018 Mar . Hauke Jan, Horvath Judit, Groß Eva, Gehrig Andrea, Honisch Ellen, Hackmann Karl, Schmidt Gunnar, Arnold Norbert, Faust Ulrike, Sutter Christian, Hentschel Julia, Wang-Gohrke Shan, Smogavec Mateja, Weber Bernhard H F, Weber-Lassalle Nana, Weber-Lassalle Konstantin, Borde Julika, Ernst Corinna, Altmüller Janine, Volk Alexander E, Thiele Holger, Hübbel Verena, Nürnberg Peter, Keupp Katharina, Versmold Beatrix, Pohl Esther, Kubisch Christian, Grill Sabine, Paul Victoria, Herold Natalie, Lichey Nadine, Rhiem Kerstin, Ditsch Nina, Ruckert Christian, Wappenschmidt Barbara, Auber Bernd, Rump Andreas, Niederacher Dieter, Haaf Thomas, Ramser Juliane, Dworniczak Bernd, Engel Christoph, Meindl Alfons, Schmutzler Rita K, Hahnen Er |
| BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer. Breast cancer research : BCR 2018 Jan 20 (1): 7. Weber-Lassalle Nana, Hauke Jan, Ramser Juliane, Richters Lisa, Groß Eva, Blümcke Britta, Gehrig Andrea, Kahlert Anne-Karin, Müller Clemens R, Hackmann Karl, Honisch Ellen, Weber-Lassalle Konstantin, Niederacher Dieter, Borde Julika, Thiele Holger, Ernst Corinna, Altmüller Janine, Neidhardt Guido, Nürnberg Peter, Klaschik Kristina, Schroeder Christopher, Platzer Konrad, Volk Alexander E, Wang-Gohrke Shan, Just Walter, Auber Bernd, Kubisch Christian, Schmidt Gunnar, Horvath Judit, Wappenschmidt Barbara, Engel Christoph, Arnold Norbert, Dworniczak Bernd, Rhiem Kerstin, Meindl Alfons, Schmutzler Rita K, Hahnen Er |
| Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India. Cancer management and research 2018 10 6505-6516. Mehta Anurag, Vasudevan Smreti, Sharma Sanjeev Kumar, Kumar Dushyant, Panigrahi Manoj, Suryavanshi Moushumi, Gupta Gari |
| High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
| Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population. Clujul medical (1957) 2018 91 (2): 157-165. Goidescu Iulian Gabriel, Caracostea Gabriela, Eniu Dan Tudor, Stamatian Florin Vasi |
| BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017 Nov . Kotsopoulos Joanne, Willows Karla, Trat Sandra, Kim Raymond H, Volenik Alexandra, Sun Ping, Narod Steven A, Boyd Jeffrey, May Taym |
| Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing. Investigational new drugs 2017 Aug . Lee Kyoungmin, Yoo Changhoon, Kim Kyu-Pyo, Park Kyoung-Jin, Chang Heung-Moon, Kim Tae Won, Lee Jae-Lyun, Lee Woochang, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Seo Dong Wan, Lee Sung Koo, Kim Myung-Hwan, Shin Sang Hyun, Hwang Dae Wook, Song Ki Byung, Lee Jae Hoon, Kim Song Cheol, Ryoo Baek-Ye |
| The effects of CDKN2A rs3731249, rs11515, and rs3088440 polymorphisms on cancer risk. Cellular and molecular biology (Noisy-le-Grand, France) 2017 Mar 63 (3): 40-44. Dong Y, Wang X, Yang Y-W, Liu Y |
| Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response. Anti-cancer agents in medicinal chemistry 2017 Jan . Antoneeva Inna I, Abakumova Tatyana V, Dolgova Dinara R, Gening Tatyana P, Pirmamedova Sabina S, Myasnikova Dinara F, Gening Snezhanna |
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. Investigational new drugs 2016 Dec . Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari |
| Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women. Experimental and molecular pathology 2016 Jan . Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Jab?o?ski Filip, Smolarz Bea |
| Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer. International journal of clinical oncology 2015 Sep . Nakagomi Hiroshi, Sakamoto Ikuko, Hirotsu Yosuke, Amemiya Kenji, Mochiduki Hitoshi, Omata Mas |
| Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PloS one 2015 10 (6): e0128829. Cao Jin-Lin, Yuan Ping, Abuduwufuer Abudumailamu, Lv Wang, Yang Yun-Hai, Hu Ji |
| Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. Journal of the National Cancer Institute 2014 Jun 106 (6): dju091. Friebel Tara M, Domchek Susan M, Rebbeck Timothy |
| The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis. Journal of assisted reproduction and genetics 2014 Jun 31 (6): 683-8. Qin Xue, Ma Liping, Yang Shi, Zhao Jianyang, Chen Siyuan, Xie Yantong, Wang Jian, Li Taijie, He Yu, Peng Qiliu, Deng Yan, Li Shan, Qin Aipi |
| XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 2711-5. Yan Yulan, Liang Hongjie, Li Ruolin, Xie Li, Li Meng, Li Shan, Qin X |
| Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature. Current pharmaceutical design 2014 20 (11): 1632-8. Pu Danhua, Jiang Shi-Wen, Wu J |
| Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies. Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6181-6. Liu Jin-Xin, Luo Rong-Cheng, Li Rong, Li Xia, Guo Yu-Wu, Ding Da-Peng, Chen Yi-Z |
| Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast cancer research and treatment 2013 Dec 142 (3): 611-8. Ingham Sarah L, Sperrin Matthew, Baildam Andrew, Ross Gary L, Clayton Richard, Lalloo Fiona, Buchan Iain, Howell Anthony, Evans D Gareth |
| PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? The oncologist 2013 18 (10): 1083-90. Mester Jessica L, Moore Rebekah A, Eng Char |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: